338 related articles for article (PubMed ID: 24385043)
1. Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
Chang CH; Chang Y; Chen DW; Ueng SW; Lee MS
Clin Orthop Relat Res; 2014 May; 472(5):1552-7. PubMed ID: 24385043
[TBL] [Abstract][Full Text] [Related]
2. Intravenous Combined with Topical Administration of Tranexamic Acid in Primary Total Hip Arthroplasty: A Randomized Controlled Trial.
Zeng Y; Si HB; Shen B; Yang J; Zhou ZK; Kang PD; Pei FX
Orthop Surg; 2017 May; 9(2):174-179. PubMed ID: 28093896
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.
Sun Q; Li J; Chen J; Zheng C; Liu C; Jia Y
BMJ Open; 2019 Jan; 9(1):e024350. PubMed ID: 30696680
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
Charoencholvanich K; Siriwattanasakul P
Clin Orthop Relat Res; 2011 Oct; 469(10):2874-80. PubMed ID: 21512813
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of different modes of using tranexamic acid administration on reducing hidden blood loss in total hip arthroplasty].
Ni JR; Wang LX; Chen XJ
Zhongguo Gu Shang; 2016 Aug; 29(8):713-717. PubMed ID: 29282929
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration.
Yi Z; Bin S; Jing Y; Zongke Z; Pengde K; Fuxing P
J Bone Joint Surg Am; 2016 Jun; 98(12):983-91. PubMed ID: 27307358
[TBL] [Abstract][Full Text] [Related]
7. What is the Ideal Route of Administration of Tranexamic Acid in TKA? A Randomized Controlled Trial.
Lee SY; Chong S; Balasubramanian D; Na YG; Kim TK
Clin Orthop Relat Res; 2017 Aug; 475(8):1987-1996. PubMed ID: 28283902
[TBL] [Abstract][Full Text] [Related]
8. Matched cohort study of topical tranexamic acid in cementless primary total hip replacement.
Sanz-Reig J; Mas Martinez J; Verdu Román C; Morales Santias M; Martínez Gimenez E; Bustamante Suarez de Puga D
Eur J Orthop Surg Traumatol; 2018 Oct; 28(7):1335-1339. PubMed ID: 29594527
[TBL] [Abstract][Full Text] [Related]
9. Topical administration of tranexamic acid in hip arthroplasty.
Kang JS; Moon KH; Kim BS; Yang SJ
Int Orthop; 2017 Feb; 41(2):259-263. PubMed ID: 27087627
[TBL] [Abstract][Full Text] [Related]
10. [Effect of tranexamic acid on blood loss and soft-tissue swelling following cemented total hip replacement].
Gombár C; Gálity H; Bácsi M; Sisák K
Orv Hetil; 2019 Mar; 160(12):456-463. PubMed ID: 30876382
[TBL] [Abstract][Full Text] [Related]
11. Topical Application of Tranexamic Acid Plus Diluted Epinephrine Reduces Postoperative Hidden Blood Loss in Total Hip Arthroplasty.
Gao F; Sun W; Guo W; Li Z; Wang W; Cheng L
J Arthroplasty; 2015 Dec; 30(12):2196-200. PubMed ID: 26145190
[TBL] [Abstract][Full Text] [Related]
12. Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study.
Morales Santias M; Mas Martinez J; Sanz-Reig J; Martínez Gimenez E; Verdu Román C; Bustamante Suarez de Puga D
Eur J Orthop Surg Traumatol; 2020 Aug; 30(6):1003-1008. PubMed ID: 32185573
[TBL] [Abstract][Full Text] [Related]
13. Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.
Konig G; Hamlin BR; Waters JH
J Arthroplasty; 2013 Oct; 28(9):1473-6. PubMed ID: 23886406
[TBL] [Abstract][Full Text] [Related]
14. High-dose (3 g) topical tranexamic acid has higher potency in reducing blood loss after total knee arthroplasty compared with low dose (500 mg): a double-blind randomized controlled trial.
Tammachote N; Raphiphan R; Kanitnate S
Eur J Orthop Surg Traumatol; 2019 Dec; 29(8):1729-1735. PubMed ID: 31359178
[TBL] [Abstract][Full Text] [Related]
15. Effect of topical tranexamic acid in total hip arthroplasty patients who receive continuous aspirin for prevention of cardiovascular or cerebrovascular events: A prospective randomized study.
Qiu J; Sun X; Zhang W; Ke X; Yang G; Zhang L
Orthop Traumatol Surg Res; 2019 Nov; 105(7):1327-1332. PubMed ID: 31570210
[TBL] [Abstract][Full Text] [Related]
16. Dose optimization of topical tranexamic acid for primary total hip arthroplasty: A prospective cohort study.
Yamaguchi A; Goto K; Kawai T; Kuroda Y; Sano K; Matsuda S
J Orthop Sci; 2019 Mar; 24(2):275-279. PubMed ID: 30279133
[TBL] [Abstract][Full Text] [Related]
17. Comparison between topical and intravenous administration of tranexamic acid in primary total hip arthroplasty.
Ueno M; Sonohata M; Fukumori N; Kawano S; Kitajima M; Mawatari M
J Orthop Sci; 2016 Jan; 21(1):44-7. PubMed ID: 26755385
[TBL] [Abstract][Full Text] [Related]
18. Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial.
Yue C; Kang P; Yang P; Xie J; Pei F
J Arthroplasty; 2014 Dec; 29(12):2452-6. PubMed ID: 24793893
[TBL] [Abstract][Full Text] [Related]
19. Optimal route for administering tranexamic acid in primary unilateral total hip arthroplasty: Results from a multicenter cohort study.
Xie J; Zhang S; Chen G; Xu H; Zhou Z; Pei F
Br J Clin Pharmacol; 2019 Sep; 85(9):2089-2097. PubMed ID: 31236973
[TBL] [Abstract][Full Text] [Related]
20. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty.
Gilbody J; Dhotar HS; Perruccio AV; Davey JR
J Arthroplasty; 2014 Apr; 29(4):681-4. PubMed ID: 24095586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
